{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T18:50:15Z","timestamp":1768589415976,"version":"3.49.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T00:00:00Z","timestamp":1685059200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T00:00:00Z","timestamp":1685059200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JSPS KAKENHI, Grant Number 18K09820"],"award-info":[{"award-number":["JSPS KAKENHI, Grant Number 18K09820"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The incidence of multicentric oral cancer is increasing. However, treatment encounters difficulty if each tumor needs to be treated simultaneously. The objective of this clinical case report is to highlight the effect of concurrent chemoradiotherapy with retrograde superselective intra-arterial infusion combined with systemic administration of cetuximab on synchronous multifocal oral squamous cell carcinomas.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 70-year-old man presented to the hospital with multiple tumors and oral pain. Three independent tumors were found in the right dorsal tongue, left edge of the\u00a0tongue, and left lower lip. Based on the characteristic appearance of the lesions and further evaluation, clinical diagnoses of right tongue cancer \u201cT3\u201d, left tongue cancer \u201cT2\u201d and lower left lip cancer \u201cT1\u201d, N2cM0 were made. Treatment was initiated with systemic administration of cetuximab, followed by intra-arterial chemoradiotherapy. Treatment results were complete response on all three local lesions, and left neck dissection was performed following the initial treatment. The patient showed no evidence of recurrence during the 4\u00a0years follow-up period.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This novel combination treatment seems to be a promising strategy for patients with synchronous multifocal oral squamous cell carcinoma.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13014-023-02282-9","type":"journal-article","created":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T15:02:19Z","timestamp":1685113339000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Efficacy of concurrent chemoradiotherapy with retrograde super selective intra-arterial infusion combined with cetuximab for synchronous multifocal oral squamous cell carcinomas"],"prefix":"10.1186","volume":"18","author":[{"given":"Xuefei","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7981-3340","authenticated-orcid":false,"given":"Mitomu","family":"Kioi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichiro","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiyuki","family":"Koizumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Izumi","family":"Koike","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoji","family":"Yamanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaharu","family":"Hata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Mitsudo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,5,26]]},"reference":[{"key":"2282_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBICAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394\u2013424.","journal-title":"CA Cancer J Clin"},{"key":"2282_CR2","unstructured":"Crestopher PW, Elisabete W, Bernard WS, editors. World Cancer Report 2020: cancer research for cancer prevention. International Agency for Research on Cancer; 2020. p. 310\u2013316."},{"issue":"4\u20136","key":"2282_CR3","first-page":"165","volume":"25","author":"Y Ota","year":"2000","unstructured":"Ota Y, Aoki T, Karakida K, Yamazaki H, Makuuchi H, Chino O, Miyasaka M. Simultaneous treatment of multiple primary cancers of the oral cavity and other sites. Tokai J Exp Clin Med. 2000;25(4\u20136):165\u201371.","journal-title":"Tokai J Exp Clin Med"},{"key":"2282_CR4","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1054\/ijom.2001.0194","volume":"31","author":"S Henning","year":"2002","unstructured":"Henning S, Maximilian UJ. Prospective evaluation of quality of life after oncologic surgery for oral cancer. Int J Oral Maxillofac Surg. 2002;31:427\u201333.","journal-title":"Int J Oral Maxillofac Surg"},{"key":"2282_CR5","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.radonc.2014.03.005","volume":"111","author":"K Mitsudo","year":"2014","unstructured":"Mitsudo K, Koizumi T, Iida M, Toshinori I, Hideyuki N, Senri O, Mitomu K, Makoto H, Izumi K, Masaharu H, et al. Retrograde superselective intra-arterial chemotherapy and daily concurrent radiotherapy for stage III and IV oral cancer: analysis of therapeutic results in 112 cases. Radiother Oncol. 2014;111:306\u201310.","journal-title":"Radiother Oncol"},{"key":"2282_CR6","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.oraloncology.2018.02.002","volume":"79","author":"K Mitsudo","year":"2018","unstructured":"Mitsudo K, Hayashi Y, Minamiyama S, Nobuhide O, Masaki I, Toshinori I, Senri O, Toshiyuki K, Mitomu K, Makoto H, et al. Chemoradiotherapy using retrograde superselective intra-arterial infusion for tongue cancer: analysis of therapeutic results in 118 cases. Oral Oncol. 2018;79:71\u20137.","journal-title":"Oral Oncol"},{"issue":"2","key":"2282_CR7","doi-asserted-by":"publisher","first-page":"246","DOI":"10.3892\/mco.2016.928","volume":"5","author":"T Naruse","year":"2016","unstructured":"Naruse T, Yanamoto S, Matsushita Y, Sakamoto Y, Morishita K, Ohba S, Shiraishi T, Yamada S, Asaba I, Umeda M. Cetuximab for the treatment of locally advanced and recurrent\/metastatic oral cancer: an investigation of distant metastasis. Mol Clin Oncol. 2016;5(2):246\u201352.","journal-title":"Mol Clin Oncol"},{"issue":"4","key":"2282_CR8","doi-asserted-by":"publisher","first-page":"626","DOI":"10.3174\/ajnr.A2054","volume":"31","author":"W Bou-Assaly","year":"2010","unstructured":"Bou-Assaly W, Mukherji S. Cetuximab (Erbitux). Am J Neuroradiol. 2010;31(4):626\u20137.","journal-title":"Am J Neuroradiol"},{"key":"2282_CR9","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S1368-8375(98)00018-9","volume":"34","author":"I Tohnai","year":"1998","unstructured":"Tohnai I, Fuwa N, Hayashi Y, Kaneko R, Tomaru Y, Hibino Y, Ueda M. New superselective intra-arterial infusion via superficial temporal artery for cancer of the tongue and tumour tissue platinum concentration after carboplatin (CBDCA) infusion. Oral Oncol. 1998;34:387\u201390.","journal-title":"Oral Oncol"},{"issue":"7","key":"2282_CR10","doi-asserted-by":"publisher","first-page":"e39","DOI":"10.1038\/cti.2015.14","volume":"4","author":"L Doessegger","year":"2015","unstructured":"Doessegger L, Banholzer ML. Clinical development methodology for infusion-related reactions with monoclonal antibodies. Clin Transl Immunol. 2015;4(7):e39.","journal-title":"Clin Transl Immunol"},{"key":"2282_CR11","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.radonc.2013.10.010","volume":"110","author":"G Vincent","year":"2014","unstructured":"Vincent G, Kian A, Wilfried B, Cai G, Marc H, Johannes AL, Anne L, Quynh-Thu L, Philippe M, Chris N, et al. Delineation of the neck node levels for head and neck tumors: a 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI RTOG. TROG consensus guidelines. Radiother Oncol. 2014;110:172\u201381.","journal-title":"Radiother Oncol"},{"key":"2282_CR12","first-page":"21","volume":"56","author":"EJ Burkes","year":"1973","unstructured":"Burkes EJ. Multiple cancers of the oral cavity. N Carolina Dental J. 1973;56:21\u20133.","journal-title":"N Carolina Dental J"},{"key":"2282_CR13","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1368-8375(98)00105-5","volume":"35","author":"F Cianfriglia","year":"1999","unstructured":"Cianfriglia F, DiGregorio DA, Manieri A. Multiple primary tumours in patients with oral squamous cell carcinoma. Oral Oncol. 1999;35:157\u201363.","journal-title":"Oral Oncol"},{"key":"2282_CR14","first-page":"1358","volume":"16","author":"S Warren","year":"1932","unstructured":"Warren S, Gate O. Multiple primary malignant tumors. A survey of the literature and a statistical study. Am J Cancer. 1932;16:1358\u2013414.","journal-title":"Am J Cancer"},{"issue":"2","key":"2282_CR15","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/1097-0142(196103\/04)14:2<221::AID-CNCR2820140202>3.0.CO;2-6","volume":"14","author":"CG Moertel","year":"1961","unstructured":"Moertel CG, Dockerty MB, Baggenstoss AH. Multiple primary malignant neoplasms: tumours of multicentric origin. Cancer. 1961;14(2):221\u20139.","journal-title":"Cancer"},{"key":"2282_CR16","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1002\/1097-0142(19941001)74:7<1933::AID-CNCR2820740718>3.0.CO;2-X","volume":"74","author":"LH Schwartz","year":"1994","unstructured":"Schwartz LH, Ozsahin M, Zhang GN, Touboul E, de Vataire F, Andolenko P, Lacau-Saint-Guily J, Laugier A, Schlienger M. Synchronous and metachronous head and neck. Cancer. 1994;74:1933\u20138.","journal-title":"Cancer"},{"issue":"4","key":"2282_CR17","doi-asserted-by":"publisher","first-page":"581","DOI":"10.5981\/jjhnc1974.29.581","volume":"29","author":"T Sato","year":"2003","unstructured":"Sato T, Kamata S, Kawabata K, Nigauri T, Mitani H, Yoshimoto S, Yonekawa H, Miura K, Beppu T, Yonekawa H, et al. A study of the treatment of oral multiple primary cancers. Head Neck Cancer. 2003;29(4):581\u20136.","journal-title":"Head Neck Cancer"},{"issue":"4","key":"2282_CR18","doi-asserted-by":"publisher","first-page":"589","DOI":"10.5631\/jibirin.83.589","volume":"83","author":"K Okamoto","year":"1990","unstructured":"Okamoto K, Sato K, Uno K, Koike S. Multicentric carcinoma in the oral cavity and pharynx; a report of eight cases. Pract Otol Pract Otol. 1990;83(4):589\u201394.","journal-title":"Pract Otol Pract Otol"},{"issue":"1","key":"2282_CR19","first-page":"120","volume":"5","author":"LB Anilkumar","year":"2016","unstructured":"Anilkumar LB, Sudarshan R. Multifocal carcinoma of oral cavity: a case report. JKIMSU. 2016;5(1):120\u20135.","journal-title":"JKIMSU"},{"issue":"2","key":"2282_CR20","doi-asserted-by":"publisher","first-page":"257","DOI":"10.5843\/jsot.4.257","volume":"4","author":"K Shionoya","year":"1992","unstructured":"Shionoya K, Okabe S, Matsuki K, Endo T, Matsuki S, Izumo T, Kirita T, Amagasa T. Clinical evaluation of the oral multiple primary cancer. J Jpn Soc Oral Tumor. 1992;4(2):257\u201363.","journal-title":"J Jpn Soc Oral Tumor"},{"issue":"1","key":"2282_CR21","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S1470-2045(09)70311-0","volume":"11","author":"AB James","year":"2010","unstructured":"James AB, Paul MH, Jordi G, Roger BC, Christopher UJ, Ranjan KS, David R, Jose B, Sharon AS, et al. Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival. Lancet Oncol. 2010;11(1):21\u20138.","journal-title":"Lancet Oncol"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-023-02282-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13014-023-02282-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-023-02282-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T15:06:57Z","timestamp":1685113617000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-023-02282-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,26]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2282"],"URL":"https:\/\/doi.org\/10.1186\/s13014-023-02282-9","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,26]]},"assertion":[{"value":"5 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present study was approved by the Ethics Committee of Yokohama City University Hospital (approval no. B200600074).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"90"}}